Comparative Epidemiology of Influenza B Yamagata-and Victoria-Lineage Viruses in Households

American Journal of Epidemiology

Volumn 182, Issue 8, 2014, Pages 705-713

  Xu, Cuiling ^a   Chan, Kwok Hung ^a   Tsang, Tim K ^a   Fang, Vicky J ^a   Fung, Rita O P ^a   Ip, Dennis K M ^a   Cauchemez, Simon ^a   Leung, Gabriel M ^a   Peiris, J S Malik ^a   Cowling, Benjamin J ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Disease transmission; influenza; influenza B virus; Victoria lineage; Yamagata lineage

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

COMPARATIVE STUDY; DISEASE TRANSMISSION; EPIDEMIOLOGY; INFECTIOUS DISEASE; INFLUENZA; POLYMERASE CHAIN REACTION; RESPIRATORY DISEASE; RISK ASSESSMENT;

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CHILD; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE TRANSMISSION; FOLLOW UP; HAZARD RATIO; HIGH RISK PATIENT; HONG KONG; HOUSEHOLD; HUMAN; INFECTION RISK; INFLUENZA B; INFLUENZA B VIRUS; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MULTICENTER STUDY; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCHOOL CHILD; SECONDARY INFECTION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION; YOUNG ADULT; CLASSIFICATION; COMPARATIVE STUDY; FAMILY SIZE; FEMALE; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; MALE; MORTALITY; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; VIROLOGY;

CHINA; HONG KONG;

INFLUENZA B VIRUS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FAMILY CHARACTERISTICS; FEMALE; FOLLOW-UP STUDIES; HONG KONG; HUMANS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OUTPATIENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 84944235926     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv110     Document Type: Article

References (47)

1. Rota PA, Wallis TR, Harmon MW, et al. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology. 1990;175(1):59-68.
2. Nerome R, Hiromoto Y, Sugita S, et al. Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism. Arch Virol. 1998;143(8):1569-1583.
3. Nakagawa N, Kubota R, Maeda A, et al. Heterogeneity of influenza B virus strains in one epidemic season differentiated by monoclonal antibodies and nucleotide sequences. J Clin Microbiol. 2000;38(9):3467-3469.
4. ShawMW, Xu X, Li Y, et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology. 2002;303(1): 1-8.
5. Chen R, Holmes EC. The evolutionary dynamics of human influenza B virus. J Mol Evol. 2008;66(6):655-663.
6. Chan PK, Chan MC, Cheung JL, et al. Influenza B lineage circulation and hospitalization rates in a subtropical city, Hong Kong, 2000-2010. Clin Infect Dis. 2013;56(5):677-684.
7. Feng L, Shay DK, Jiang Y, et al. Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008. Bull World Health Organ. 2012;90(4):279-288B.
8. Olson DR, Heffernan RT, Paladini M, et al. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med. 2007;4(8):e247.
9. Socan M, Prosenc K, Ucakar V, et al. A comparison of the demographic and clinical characteristics of laboratoryconfirmed influenza B Yamagata and Victoria lineage infection. J Clin Virol. 2014;61(1):156-160.
10. Tan Y, Guan W, Lam TT-Y, et al. Differing epidemiological dynamics of influenza B virus lineages in Guangzhou, southern China, 2009-2010. J Virol. 2013;87(22):12447-12456.
11. Vijaykrishna D, Holmes EC, Joseph U, et al. The contrasting phylodynamics of human influenza B viruses. eLife. 2015;4: e05055.
12. Cowling BJ, Chan K-H, Fang VJ, et al. Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med. 2009;151(7):437-446.
13. Cowling BJ, Fung RO, Cheng CK, et al. Preliminary findings of a randomized trial of non-pharmaceutical interventions to prevent influenza transmission in households. PLoS One. 2008; 3(5):e2101.
14. Cowling BJ, Ip DK, Fang VJ, et al. Aerosol transmission is an important mode of influenza A virus spread. Nat Commun. 2013;4:1935.
15. Tsang TK, Cauchemez S, Perera RA, et al. Association between antibody titers and protection against influenza virus infection within households. J Infect Dis. 2014;210(5):684-692.
16. Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of pandemic and seasonal influenza A in households. N Engl J Med. 2010;362(23):2175-2184.
17. Lau LL, Nishiura H, Kelly H, et al. Household transmission of 2009 pandemic influenza A (H1N1): a systematic review and meta-analysis. Epidemiology. 2012;23(4):531-542.
18. Zhang N, Fang S, Wang T, et al. Applicability of a sensitive duplex real-time PCR assay for identifying B/Yamagata and B/Victoria lineages of influenza virus from clinical specimens. Appl Microbiol Biotechnol. 2012;93(2):797-805.
19. Biere B, Bauer B, Schweiger B. Differentiation of influenza B virus lineages Yamagata and Victoria by real-time PCR. J Clin Microbiol. 2010;48(4):1425-1427.
20. Cauchemez S, Donnelly CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med. 2009;361(27):2619-2627.
21. Nukiwa-Souma N, Burmaa A, Kamigaki T, et al. Influenza transmission in a community during a seasonal influenza A(H3N2) outbreak (2010-2011) in Mongolia: a community-based prospective cohort study. PLoS One. 2012; 7(3):e33046.
22. Petrie JG, Ohmit SE, Cowling BJ, et al. Influenza transmission in a cohort of households with children: 2010-2011. PLoS One. 2013;8(9):e75339.
23. Sugimoto JD, Borse NN, Ta ML, et al. The effect of age on transmission of 2009 pandemic influenza A (H1N1) in a camp and associated households. Epidemiology. 2011;22(2): 180-187.
24. Su WJ, Shao PL, Liu MT, et al. Low seroprotection against preseasonal influenza local strains in children might predict the upcoming epidemic influenza strains. Clin Infect Dis. 2010; 51(2):171-176.
25. Qi SX, Han GY, Liu YF. Virological surveillance and molecular characteristics of influenza B viruses in Hebei Province during 2004-2008 [in Chinese]. Zhongguo Yi Miao He Mian Yi. 2009;15(1):27-30.
26. Liu YZ, Zhao X, Huang YW, et al. Analysis of genetic features of influenza B virus in Hunan Province from 2007 to 2010 [in Chinese]. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46(3): 258-263.
27. Mao HY, Zhou M, Zhang YJ, et al. Genetic variation of the hemagglutinin and neuraminidase of influenza B viruses isolated in Zhejiang Province during 1999-2010 [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 2011;32(4):376-381.
28. Huang WJ, Tan MJ, Lan Y, et al. Virological characterization of influenza B virus in mainland China during 2011-2012 [in Chinese]. Bing Du Xue Bao. 2013;29(1):32-38.
29. Chinese Center for Disease Control and Prevention. Chinese Influenza and Human Avian Influenza Weekly Report [in Chinese]. (Issue 11, total issue 23). http://www. cnic. org. cn/uploadfile/2014/1128/20141128112032445. pdf. Published August 19, 2009. Updated August 19, 2009. Accessed October 10, 2014.
30. Ng S, Fang VJ, Ip DK, et al. Humoral antibody response after receipt of inactivated seasonal influenza vaccinations one year apart in children. Pediatr Infect Dis J. 2012;31(9):964-969.
31. Domachowske JB, Pankow-Culot H, Bautista M, et al. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years. J Infect Dis. 2013;207(12):1878-1887.
32. Langley JM, Carmona Martinez A, Chatterjee A, et al. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis. 2013;208(4):544-553.
33. Skowronski DM, Hamelin ME, Janjua NZ, et al. Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance. PLoS One. 2012;7(6):e38929.
34. Skowronski DM, Hottes TS, De Serres G, et al. Influenza B/Victoria antigen induces strong recall of B/Yamagata but lower B/Victoria response in children primed with two doses of B/Yamagata. Pediatr Infect Dis J. 2011;30(10):833-839.
35. Cao B, Li X-W, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361(26):2507-2517.
36. Leung YH, Lim WL, Wong MH, et al. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus. Epidemiol Infect. 2012;140(5):814-817.
37. Li CC,Wang L, Eng HL, et al. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children. Emerg Infect Dis. 2010;16(8): 1265-1272.
38. Hien TT, Boni MF, Bryant JE, et al. Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis. PLoS Med. 2010; 7(5):e1000277.
39. Yu H, Liao Q, Yuan Y, et al. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ. 2010; 341:c4779.
40. Bhattarai A, Villanueva J, Palekar RS, et al. Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak-Pennsylvania, May-June 2009. Clin Infect Dis. 2011;52(suppl 1):S102-S108.
41. Cauchemez S, Carrat F, Viboud C, et al. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Stat Med. 2004;23(22): 3469-3487.
42. Petrie JG, Ohmit SE, Johnson E, et al. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis. 2011;203(9):1309-1315.
43. Ng S, Cowling BJ, Fang VJ, et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis. 2010;50(5):707-714.
44. Cowling BJ, Fang VJ, Riley S, et al. Estimation of the serial interval of influenza. Epidemiology. 2009;20(3): 344-347.
45. Levy JW, Cowling BJ, Simmerman JM, et al. The serial intervals of seasonal and pandemic influenza viruses in households in Bangkok, Thailand. Am J Epidemiol. 2013; 177(12):1443-1451.
46. Klinkenberg D, Nishiura H. The correlation between infectivity and incubation period of measles, estimated from households with two cases. J Theor Biol. 2011;284(1):52-60.
47. Poon LL, Chan KH, Chu DK, et al. Viral genetic sequence variations in pandemic H1N1/2009 and seasonal H3N2 influenza viruses within an individual, a household and a community. J Clin Virol. 2011;52(2):146-150.